| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/16/2013 | US8420115 Oral preparations and process for production thereof |
| 04/16/2013 | US8420114 Alpha and beta adrenergic receptor agonists for treatment of pain and / or inflammation |
| 04/16/2013 | US8420108 Flexible bone composite |
| 04/16/2013 | US8420105 Botulinum toxin administration to treat various conditions |
| 04/16/2013 | US8420095 Antigen-containing microspheres for the treatment of allergies |
| 04/16/2013 | US8420062 Non-aerosol/aerosol dispensing of sunscreen sprays comprising spherical porous silica microparticles |
| 04/16/2013 | US8420060 Pharmaceutical aerosol formulations of formoterol and beclometasone dipropionate |
| 04/16/2013 | US8420059 Aerosol composition |
| 04/16/2013 | US8420058 Pharmaceutical aerosol composition |
| 04/16/2013 | US8420057 Capsule having broad color spectrum |
| 04/16/2013 | US8420055 Amine functionalized superparamagnetic nanoparticles for the synthesis of bioconjugates and uses therefor |
| 04/16/2013 | US8419803 Calcium phosphate cements and methods for using the same |
| 04/16/2013 | US8419715 Medical device with an energy supply having at least two energy sources |
| 04/16/2013 | US8419470 Coaxial connector having detachable locking sleeve |
| 04/16/2013 | CA2577938C Delivering functional nucleic acids to mammalian cells via bacterially derived, intact minicells |
| 04/16/2013 | CA2577709C Multi-cap reservoir devices for controlled release or exposure of reservoir contents |
| 04/16/2013 | CA2566655C Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
| 04/16/2013 | CA2558623C Surface directed cellular attachment |
| 04/16/2013 | CA2550256C Topical formulations comprising a 1-n-arylpyrazole derivative and a formamidine |
| 04/16/2013 | CA2541811C Drug-delivery vehicles based on reversed liquid crystalline phase materials |
| 04/16/2013 | CA2538755C Granular jelly drink capable of masking bitterness |
| 04/16/2013 | CA2527722C Biodegradable poly(beta-amino esters) and uses thereof |
| 04/16/2013 | CA2490959C Radiolabeled compounds and liposomes and their methods of making and using the same |
| 04/16/2013 | CA2484512C Treatment of cataracts and other ophthalmic diseases |
| 04/16/2013 | CA2475968C A coating for implantable medical devices to control drug elution from abasecoat |
| 04/16/2013 | CA2431521E Steroid hormone products and methods for preparing them |
| 04/14/2013 | CA2785504A1 Use of inhaled nitrous oxide or xenon to prevent neuropathic pain caused by anti-cancer chemotherapy |
| 04/11/2013 | WO2013052958A2 Antimicrobial compositions and methods employing same |
| 04/11/2013 | WO2013052889A1 Nasal delivery mechanism for prophylactic and post-acute use for progesterone and/or its enantiomer for use in treatment of mild traumatic brain injuries |
| 04/11/2013 | WO2013052849A2 Prophylactic and post-acute use of progesterone to better outcomes associated with concussion |
| 04/11/2013 | WO2013052844A1 Methods for treating and diagnosing respiratory tract infections |
| 04/11/2013 | WO2013052760A1 Compositions for the treatment of dry eye |
| 04/11/2013 | WO2013052167A2 Membrane encapsulated nanoparticles and method of use |
| 04/11/2013 | WO2013052158A2 Targeted nanovectors and their use for treatment of brain tumors |
| 04/11/2013 | WO2013052053A1 Transfection sheets and methods of use |
| 04/11/2013 | WO2013052019A1 Production method for effervescent formulations comprising diclofenac |
| 04/11/2013 | WO2013051773A1 Composition for preventing and treating actinobacillus pleuropneumoniae infection |
| 04/11/2013 | WO2013051732A1 Liposome composite body |
| 04/11/2013 | WO2013051363A1 Magnetic composition, and method for producing same |
| 04/11/2013 | WO2013051036A1 Use of pharmaceutical composition for gastroretentive sustained and pulsatile drug delivery system |
| 04/11/2013 | WO2013050637A1 Oxoisoaporphine nanocapsules for treating depression |
| 04/11/2013 | WO2013050562A1 Composition comprising anolyte and carbonate |
| 04/11/2013 | WO2013050539A2 Tamper-resistant oral pharmaceutical dosage form comprising opioid agonist and opioid antagonist |
| 04/11/2013 | WO2013050511A1 Edible web comprising microorganisms |
| 04/11/2013 | WO2013050419A1 Pharmaceutical compositions comprising 40 - o - ( 2 - hydroxy) ethyl - rapamycin |
| 04/11/2013 | WO2013050404A1 Composition for the treatment of fistula |
| 04/11/2013 | WO2013050339A1 Pharmaceutical compositions of antihypertensives |
| 04/11/2013 | WO2013050280A1 Formulas for diagnosing and treating hormone-dependent cancers and cancers of the organs responsible for steroid hormone synthesis |
| 04/11/2013 | WO2013050169A1 Method for producing a homogeneous powder mixture and method for producing an implant and implant |
| 04/11/2013 | WO2013050162A1 Process line for the production of freeze-dried particles |
| 04/11/2013 | WO2013050156A1 Process line for the production of freeze-dried particles |
| 04/11/2013 | WO2013050017A1 Molecule mixture comprising an amphipathic molecule type a, which has a positive total charge in the hydrophilic range, and an amphipathic molecule type b and a polyphenol c, method for producing said molecule mixture and use thereof |
| 04/11/2013 | WO2013049941A1 Liposome compositions comprising an adjuvant that activates or increases the activity of tlr2 and uses thereof |
| 04/11/2013 | WO2013022410A3 Production method for effervescent formulations comprising dexketoprofen |
| 04/11/2013 | WO2013019151A3 Oxide ferrimagnetics with spinel structure nanoparticles and iron oxide nanoparticles, biocompatible aqueous colloidal systems comprising nanoparticles, ferriliposomes, and uses thereof |
| 04/11/2013 | WO2013017686A8 Protective-film changer |
| 04/11/2013 | WO2013016697A3 17-hydroxyprogesterone ester-containing oral compositions and related methods |
| 04/11/2013 | WO2013015599A3 Pharmaceutical composition for oral administration comprising bisphosphonic acid or its salt |
| 04/11/2013 | WO2013012835A3 Sirna useful in the treatment of flavivirus infection |
| 04/11/2013 | WO2013012662A3 Pharmaceutical compositions for rectal administration |
| 04/11/2013 | WO2013009142A3 Sustained/release pharmaceutical composition comripising choline alfoscerate or pharmaceutically acceptable salt thereof and method for manufacturing the same |
| 04/11/2013 | WO2013007584A8 Method for sterilising functionalised coated surfaces containing nucleotides and/or nucleotide derivatives |
| 04/11/2013 | WO2013006569A3 Herpes virus vaccine and methods of use |
| 04/11/2013 | WO2013004716A9 Peptide beads |
| 04/11/2013 | WO2012169938A3 Device and methods for the culturing, storage and cryopreservation of stem and differentiated cells of human and animal origin |
| 04/11/2013 | WO2012072245A3 Exopolysaccharide for the treatment and/or care of the skin, mucous membranes, hair and/or nails |
| 04/11/2013 | WO2012042224A8 Pharmaceutical composition comprising deferasirox |
| 04/11/2013 | WO2012028922A8 Controlled release pharmaceutical compositions of milnacipran |
| 04/11/2013 | US20130090633 Osmotic patch pump |
| 04/11/2013 | US20130090591 Localization of agents at a target site with a composition and an energy source |
| 04/11/2013 | US20130090539 Fluorochrome material and method for using the same |
| 04/11/2013 | US20130090392 One step method for the preparation of water/oil/water type multiple emulsion |
| 04/11/2013 | US20130090387 Stabilized compositions comprising a therapeutically active agent and an oxidizing preservative |
| 04/11/2013 | US20130090384 Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid |
| 04/11/2013 | US20130090237 Pteredin pentanedioic derivative based nanoparticles |
| 04/11/2013 | US20130089617 Crystalline microparticles of a beta-agonist coated with a fatty acid |
| 04/11/2013 | US20130089616 Sustained-release nanoparticle compositions and methods for using the same |
| 04/11/2013 | US20130089615 Compositions of Jasmonate Compounds and Methods of Use |
| 04/11/2013 | US20130089614 Magnetic Nanoparticles and Uses Thereof |
| 04/11/2013 | US20130089612 R(+)-n-formyl-propargyl-aminoindan |
| 04/11/2013 | US20130089611 Rasagiline citramide |
| 04/11/2013 | US20130089610 R(+)-n-methyl-propargyl-aminoindan |
| 04/11/2013 | US20130089609 Controlled release nucleated tablet |
| 04/11/2013 | US20130089608 Sustained Release Pharmaceutical Compositions for Highly Water Soluble Drugs |
| 04/11/2013 | US20130089607 Once daily trospium chloride treatment method |
| 04/11/2013 | US20130089604 Solid Oral Dosage Form Containing An Enhancer |
| 04/11/2013 | US20130089603 Compositions and methods for treating obesity and obesity-related conditions |
| 04/11/2013 | US20130089602 Encapsulated chelator |
| 04/11/2013 | US20130089600 Cannabinoid formulations |
| 04/11/2013 | US20130089599 Nano-encapsulated therapeutics for controlled treatment of infection and other diseases |
| 04/11/2013 | US20130089598 Method of treating pulmonary disorders with liposomal amikacin formulations |
| 04/11/2013 | US20130089597 MicroRNA-130a,b as a Tumor Suppressor and Sensitizing Agent for Chemotherapy |
| 04/11/2013 | US20130089592 Method of producing a hydrogel |
| 04/11/2013 | US20130089585 Filler comprising beads |
| 04/11/2013 | US20130089575 Pharmaceutical methods and topical compositions containing acitretin |
| 04/11/2013 | US20130089574 Method of preventive on-demand hormonal contraception |
| 04/11/2013 | US20130089573 Novel process |
| 04/11/2013 | US20130087946 Buccal Drug Delivery |
| 04/11/2013 | DE102011115690A1 Quetiapin enthaltende Formulierungen Quetiapine formulations containing |
| 04/11/2013 | DE102011114951A1 Molekülmischung, umfassend eine amphipathische Molekülsorte A, welche im hydrophilen Bereich elne positive Gesamtladung aufweist und eine amphipathische Molekülsorte B sowie ein Polyphenol C, Verfahren zur Herstellung der Molekülmischung und deren Verwendung Molecule mixture comprising an amphipathic molecule Type A, which in the hydrophilic region elne overall positive charge and comprises an amphipathic molecule Type B and a polyphenol C, process for the preparation of the molecular compound and the use thereof |